MA

Mahendra Anant Chaudhari

Active Director Director DIN 08168347
DIN 08168347 First appointment Jun 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahendra Anant Chaudhari

Data last updated:

Mahendra Anant Chaudhari is a Director at Pramax Pharma Private Limited (since 2018). The company operates in Business Services.

DIN 08168347
Primary Designation Director
Industry Business Services
First Appointment 28 Jun 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pramax Pharma Private Limited U74999MH2018PTC311294
Director28 Jun 20182018Active

Board colleagues of Mahendra Anant Chaudhari

NameDINCompanyDesignation
Snehal Dilip Wani08168348Pramax Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pramax Pharma Private Limited
Premium access

Shareholding and investment profile for Mahendra Anant Chaudhari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahendra Anant Chaudhari

Mahendra Anant Chaudhari currently holds 1 directorship: Pramax Pharma Private Limited (Director, since 28 Jun 2018).

Mahendra Anant Chaudhari was first appointed on 28 Jun 2018 as Director at Pramax Pharma Private Limited.

The current boards of Mahendra Anant Chaudhari's companies include Snehal Dilip Wani (Pramax Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available